Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care

[1]  N. Fleischer,et al.  Craniofacial features of 3q29 deletion syndrome: Application of next‐generation phenotyping technology , 2020, medRxiv.

[2]  E. Walker,et al.  Comprehensive phenotyping of neuropsychiatric traits in a multiplex 3q29 deletion family: a case report , 2020, BMC Psychiatry.

[3]  Z. Warren,et al.  Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016 , 2020, Morbidity and mortality weekly report. Surveillance summaries.

[4]  L. Schieve,et al.  Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009–2017 , 2019, Pediatrics.

[5]  I. Krantz,et al.  Redefining the Etiologic Landscape of Cerebellar Malformations. , 2019, American journal of human genetics.

[6]  M. Epstein,et al.  Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry , 2019, Molecular Autism.

[7]  James G. Scott,et al.  Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016 , 2018, Schizophrenia bulletin.

[8]  E. Walker,et al.  Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome , 2018, BMC Psychiatry.

[9]  Z. Warren,et al.  Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. , 2014, Morbidity and mortality weekly report. Surveillance summaries.

[10]  B. Moreno-Küstner,et al.  Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses , 2018, PloS one.

[11]  E. Lukacz,et al.  Early Behavioral Risks of Childhood and Adolescent Daytime Urinary Incontinence and Nocturnal Enuresis , 2017, Journal of developmental and behavioral pediatrics : JDBP.

[12]  T. Nevéus.  Pathogenesis of enuresis: Towards a new understanding , 2017, International journal of urology : official journal of the Japanese Urological Association.

[13]  Wei Cheng,et al.  Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects , 2016, Nature Genetics.

[14]  Robert W. Grundmeier,et al.  The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study , 2016, BMC Pediatrics.

[15]  J. Rosenfeld,et al.  Novel features of 3q29 deletion syndrome: Results from the 3q29 registry , 2016, American journal of medical genetics. Part A.

[16]  Christina Freytag,et al.  Handbook Of Normal Physical Measurements , 2016 .

[17]  M. Butler,et al.  A clinical case report and literature review of the 3q29 microdeletion syndrome , 2015, Clinical dysmorphology.

[18]  J. Mulle.  The 3q29 deletion confers >40-fold increase in risk for schizophrenia , 2015, Molecular Psychiatry.

[19]  T. Huisman,et al.  Congenital abnormalities of the posterior fossa. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[20]  M C O'Donovan,et al.  Copy number variation in schizophrenia in Sweden , 2014, Molecular Psychiatry.

[21]  D. Kiddoo.  Nocturnal enuresis , 2012, Canadian Medical Association Journal.

[22]  K. Hovanes,et al.  The 3q29 microdeletion syndrome: Report of three new unrelated patients and in silico “RNA binding” analysis of the 3q29 region , 2011, American journal of medical genetics. Part A.

[23]  Jianxin Shi,et al.  Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. , 2011, The American journal of psychiatry.

[24]  D. Cutler,et al.  Microdeletions of 3q29 confer high risk for schizophrenia. , 2010, American journal of human genetics.

[25]  D. Hamilos,et al.  Rhinitis and sinusitis. , 2010, The Journal of allergy and clinical immunology.

[26]  A. Hamosh,et al.  3q29 interstitial microdeletion syndrome: an inherited case associated with cardiac defect and normal cognition. , 2009, European journal of medical genetics.

[27]  R. Tervo,et al.  Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication , 2008, Molecular Cytogenetics.

[28]  N. Crepaz,et al.  Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States , 2011, Cancer Causes & Control.

[29]  J. Bousquet,et al.  The public health implications of asthma. , 2005, Bulletin of the World Health Organization.

[30]  E. Cook,et al.  3q29 Recurrent Deletion , 1993 .

[31]  B D Schmitt,et al.  Nocturnal enuresis. , 1997, Primary care.

[32]  J. Rosenfeld,et al.  Novel features of 3 q 29 deletion syndrome : Results from the 3 q 29 registry , 2022 .